Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other

Biological Psychiatry

Volumn 42, Issue 1, 1997, Pages 1-5

  Olincy, Ann ^a,b   Young, David A ^a   Freedman, Robert ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

7 nicotinic receptor; Cigarette smoking; Cotinine; Inhalation; Nicotine; Schizophrenia

Indexed keywords

COTININE; DRUG METABOLITE; NICOTINE; NICOTINIC RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; DRUG URINE LEVEL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING;

ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; REFERENCE VALUES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF ADMINISTRATION; SMOKING;

EID: 0030845507     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00302-2     Document Type: Article

References (31)

1. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R (1992): Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry 32:607-616.
2. Adler LE, Hoffer LD, Wiser A, Freedman R (1993): Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150:1856-1861.
3. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC: American Psychiatric Press.
4. Ashton H, Stepney R, Thompson JW (1979): Self-titration by cigarette smokers. Br Med J 2:357-360.
5. Benowitz NL, Kuyt F, Jacob P, Jones RT, Osman AL (1983): Cotinine disposition and effects. Clin Pharmacol Ther 14: 604-611.
6. Breslau N, Kilbney MM, Andreski P (1993): Nicotine dependence and major depression: New evidence from a prospective investigation. Arch Gen Psychiatry 50:31-35.
7. Clementz BA, Sweeney JA (1990): Is eye movement dysfunction a biological marker for schizophrenia? A methodological review. Psychol Bull 108:77-92.
8. de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM (1995): Schizophrenia and smoking: An epidemiological survey in a state hospital. Am J Psychiatry 152:453-455.
9. Endicott J, Andreasen N, Spitzer RL (1978): Family History-Research Diagnostic Criteria, 3rd ed. New York: Research Assessment and Training Unit, New York State Psychiatric Institute.
10. Freedman R, Adler LE, Bickford P, et al (1994): Schizophrenia and nicotinic receptors. Harvard Rev Psychiatry 2:179-192.
11. Freedman R, Hall M, Adler LE, Leonard S (1995): Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38:22-33.
12. Glynn SH, Sussman S (1990): Why patients smoke [letter]. Hosp Community Psychiatry 41:1027.
13. Goff DS, Henderson DC, Amico E (1992): Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. Am J Psychiatry 149:1189-1194.
14. Greenberg RA, Haley NJ, Etzel RAQ, Loda FA (1984): Measuring the exposure of infants to tobacco smoke. N Engl J Med 310:1075-1078.
15. Hill P, Marquardt H (1980): Plasma and urine changes after smoking different brands of cigarettes. Clin Pharmacol Ther 27:652-658.
16. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA (1986): Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 143:993-997.
17. Jarvis M, Tunstall-Pedoe H, Feyerabend C, Vesey C, Salloojee Y (1984): Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health 38:335-339.
18. Kirch DG, Gerhardt GA, Shelton RC, Freedman R, Wyatt RJ (1987): Effect of chronic nicotine administration on monoamine and monoamine metabolite concentrations in rat brain. Clin Neuropharmacol 10:376-383.
19. Klein C, Andresen B (1991): On the influence of smoking upon smooth pursuit eye movements in schizophrenics and normal controls. J Psychophysiol 5:361-369.
20. Marks MJ, Collins AC (1982): Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate. Mol Pharmacol 22:554-564.
21. Matsukura S, Sakamoto N, Seino Y, Tamada T, Matsuyama H, Muranaka H (1979): Cotinine excretion and daily cigarette smoking in habituated smokers. Clin Pharmacol Ther 25: 555-561.
22. McEvoy JP, Freudenreich O, Levin ED, Rose JE (1995): Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology 119:124-126.
23. McGhie A, Chapman JS (1961): Disorders of attention and perception in early schizophrenia. Br J Med Psychol 34:103-117.
24. Miller RR (1977): Effects of smoking on drug action. Pharmacol Ther 2:749-756.
25. Olincy A, Ross RG, Roath M, Freedman R (1995): Smooth pursuit eye movements and cigarette smoking in schizophrenia. Soc Neurosci Abs 21:747.
26. Seguela P, Wadiche I, Dinley-Miller K, Dani J, Patrick JW (1993): Molecular cloning, functional properties, and distribution of rat brain alpha-7: A nicotinic channel highly permeable to calcium. J Neurosci 13:596-604.
27. Slifer BL (1983): Schedule-induction of nicotine self administration. Pharmacol Biochem Behav 19:1005-1009.
28. Spitzer RL, Williams JBW, Gibbon M, First MB (1990a): Structured Interview for DSM-III-R - Patient Edition (SCID-P, Version 1.0). Washington, DC: American Psychiatric Press.
29. Spitzer RL, Williams JBW, Gibbon M, First MB (1990b): Structured Interview for DSM-III-R - Non-Patient Edition (SCID-NP, Version 1.0). Washington, DC: American Psychiatric Press.
30. Venables P (1964): Input dysfunction in schizophrenia. Prog Exp Pers Res 1:1-47.
31. Wald NJ, Boreham J, Bailey A, Ritchie C, Haddow JE, Knight G (1984): Urinary cotinine as a measure of breathing other people's tobacco smoke. Lancet i:230-231.